Last updated on July 2013

A randomized, double-blind, parallel-group study of Cardiovascular safety in Osteoarthritis or Rheumatoid Arthritis patients with or at high risk for Cardiovascular disease comparing Celecoxib with Naproxen and Ibuprofen.


Brief description of study

A randomized, double-blind, parallel-group study of Cardiovascular safety in Osteoarthritis or Rheumatoid Arthritis patients with or at high risk for Cardiovascular disease comparing Celecoxib with Naproxen and Ibuprofen.

Detailed Study Description

Do you have Rheumatoid Arthritis? You may qualify to participate in a clinical research study.

This is a randomized, double blind, parallel-group study of cardiovascular disease comparing Celecoxib with Naproxen and Ibuprofen. The study is for a 42 week period. The data from this trial will significantly add to our understanding of the cardiovascular safety of nonsteroidal use in our patients.

Clinical Study Identifier: TX1282

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

The Center for Rheumatology and ...

The Center for Rheumatology and Bone Research
Wheaton, MD USA
  Connect »